Zhejiang Hisun Pharmaceutical Co., Ltd. provided that the Company predicts the net profit belonging to shareholders of the listed company in the first half of 2020 will be between RMB 205,000,000 and RMB 255,000,000, with an increase of between RMB 152,370,000 and RMB 202,370,000 compared with the same period of 2019 and with a year-on-year increase of between 290% and 385%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in the 1st half of 2020 will be between RMB 130,000,000 and RMB 165,000,000, with an increase of between RMB 124,540,000 and RMB 159,540,000 compared with the same period of 2019.